Rhythm Pharmaceuticals (RYTM) total assets

Total assets · fiscal 2025
$480.20M

Rhythm Pharmaceuticals (RYTM) had total assets of $480.20M at the end of fiscal 2025 (December 31, 2025). That is 22.4% higher than the $392.27M of fiscal 2024. Figures as of 18 Nov 2026, 01:23 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$480.20M
Change on fiscal 2024
+22.4%
Growth, 5 years
+20.7% a year
Highest on record
$480.20Mfiscal 2025
Lowest on record
$12.34Mfiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Rhythm Pharmaceuticals total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 20.7% a year. Across the 10 fiscal years on record (2016–2025), the highest was $480.20M in fiscal 2025 and the lowest $12.34M in fiscal 2016.

History · 10 fiscal years

Total assets by fiscal year

Rhythm Pharmaceuticals total assets, year by year

Rhythm Pharmaceuticals (RYTM) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$480.20M 22.4% up
2024$392.27M 17.9% up
2023$332.75M 13.0% down
2022$382.48M 16.1% up
2021$329.52M 76.1% up
2020$187.07M 39.4% down
2019$308.52M 18.6% up
2018$260.21M 71.5% up
2017$151.74M 1,129.7% up
2016$12.34M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Rhythm Pharmaceuticals and comparable companies
CompanyTotal assetsFiscal year
Rhythm Pharmaceuticals RYTM$480.20M2025
Alkermes ALKS$2.49B2025
PACS Group PACS$5.58B2025
Kiniksa Pharmaceuticals International KNSA$763.63M2025
ImmunityBio IBRX$501.90M2025
Cytokinetics CYTK$1.42B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RYTM

Rhythm Pharmaceuticals, figure by figure

Rhythm Pharmaceuticals (RYTM) overview: price, valuation and scorecardAll health care companies by market value

Rhythm Pharmaceuticals total assets: questions and answers

How large are Rhythm Pharmaceuticals's total assets?

Rhythm Pharmaceuticals (RYTM) had total assets of $480.20M at the end of fiscal 2025 (December 31, 2025). That is 22.4% higher than the $392.27M of fiscal 2024.

What is the growth rate of Rhythm Pharmaceuticals's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 20.7% a year.

What are the highest and lowest total assets figures on record for Rhythm Pharmaceuticals?

Across the 10 fiscal years on record (2016–2025), the highest was $480.20M in fiscal 2025 and the lowest $12.34M in fiscal 2016.

How is Rhythm Pharmaceuticals's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Rhythm Pharmaceuticals (RYTM) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/RYTM/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.